GlaxoSmithKline, Vir Biotechnology secure FDA emergency use authorization for Covid-19 antibody | 27 May 2021
GlaxoSmithKline, Vir Biotechnology secure FDA emergency use authorization for Covid-19 antibody
Source: stockmarketwire.com
Gsk L News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Gsk L. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Gsk L Today - Breaking & Trending Today
FTSE 100 slips 0.2% by midday despite mining sector rally | 27 May 2021
FTSE 100 slips 0.2% by midday despite mining sector rally
Source: stockmarketwire.com
GlaxoSmithKline, Sanofi begin phase 3 study of Covid-19 vaccine | 27 May 2021
GlaxoSmithKline, Sanofi begin phase 3 study of Covid-19 vaccine
Source: stockmarketwire.com
FTSE 100 makes rocky start; United Utilities profits fall | 27 May 2021
FTSE 100 makes rocky start; United Utilities profits fall
Source: stockmarketwire.com
GSK, Sanofi eye late-stage trial of Covid-19 vaccine in coming weeks following positive update | 17 May 2021
17 May 2021 | 07:30am StockMarketWire.com - Pharma giants GlaxoSmtihKline and Sanofi said they would move to a phase 3 trial of their Covid-19 vaccine in the coming weeks after a phase 2 trial showed 'strong' rates of immune responses in all adult age groups. 'The phase 2 study interim results show that the adjuvanted recombinant vaccine candidate triggered a strong immune response amongst adults of all age groups with 95% to 100% seroconversion rates and neutralizing antibodies that were comparable to those generated by natural infection,' GSK said. 'The phase 3 trial is expected to enro...
Source: stockmarketwire.com